IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Healthcare Value Capital, LLC

Q2 2014 Holdings

Filed 2014-08-13 | 33 holdings | $7.2M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
ANI Pharmaceuticals Inc(ANIP)COM00182C103$6.9M199,00095.7%
Cytokinetics Inc(CYTK)COM NEW23282W605$199.0K41,6662.8%
Spdr S&P 500 ETF TR(SPY)PutTR UNIT78462F103$19.6K100,0000.3%
Proshares TRCallULTSHT RUSS200074348A319$12.9K300,0000.2%
Ishares(IWM)PutRUSSELL 2000 ETF464287655$11.9K100,0000.2%
Albany Molecular Resh IncCOM012423109$10.0K498,2000.1%
Astrazeneca PLC(AZN)SPONSORED ADR046353108$7.4K100,0000.1%
Teva Pharmaceutical Inds LTD(TEVA)ADR881624209$6.8K130,0000.1%
Auxilium Pharmaceuticals IncCOM05334D107$4.6K229,4810.1%
Quest Diagnostics Inc(DGX)COM74834L100$4.5K77,2080.1%
Merck & Co Inc New(MRK)COM58933Y105$4.5K77,0000.1%
Pfizer Inc(PFE)COM717081103$4.5K150,0000.1%
Sanofi(SNY)SPONSORED ADR80105N105$3.1K57,7350.0%
Proshares TRULTSH NASD BIOT74347B409$2.8K200,0000.0%
Proshares TRCallULTSH NASD BIOT74347B409$2.8K200,0000.0%
Supernus Pharmaceuticals Inc(SUPN)CallCOM868459108$2.2K200,0000.0%
Albany Molecular Resh IncCallCOM012423109$2.0K100,0000.0%
Auxilium Pharmaceuticals IncCallCOM05334D107$2.0K100,0000.0%
Impax Laboratories IncCOM45256B101$1.5K50,0000.0%
Sorrento Therapeutics Inc(SRNE)COM NEW83587F202$1.4K204,9680.0%
Proshares TRULTSHT RUSS200074348A319$1.1K25,0000.0%
Sunesis Pharmaceuticals IncCallCOM NEW867328601$978150,0000.0%
Kindred Biosciences IncCOM494577109$93250,0000.0%
Sucampo Pharmaceuticals IncCL A864909106$66796,6300.0%
Fibrocell Science IncCOM NEW315721209$629157,7690.0%
Cempra IncCOM15130J109$53750,0000.0%
Zogenix IncCOM98978L105$503250,0000.0%
Galmed Pharmaceuticals LTD(GLMD)SHSM47238106$48750,0000.0%
Ariad Pharmaceuticals IncCOM04033A100$47875,0000.0%
Biota Pharmaceutials IncCOM090694100$415145,5070.0%
Rigel Pharmaceuticals Inc(RIGLUSD)COM NEW766559603$363100,0000.0%
Celsion CorporationCOM PAR $0.0115117N404$347100,0000.0%
Stemline Therapeutics IncCOM85858C107$24216,4640.0%